No connection

Search Results

FNB

NEUTRAL
$17.52 Live
F.N.B. Corporation · NYSE
Target $20.38 (+16.3%)
$12.88 52W Range $19.14

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 27, 2026
Market cap
$6.23B
P/E
10.81
ROE
8.9%
Profit margin
34.1%
Debt/Equity
N/A
Dividend yield
2.97%

AI Analysis

AI-powered fundamental assessment

Confidence
85%
FNB presents a stark contrast between deep value and deteriorating financial health, highlighted by a weak Piotroski F-Score of 2/9. While the stock is significantly undervalued relative to its Graham Number ($26.4) and Intrinsic Value ($47.79), and trades below book value (P/B 0.92), the deterministic health markers are concerning. Strong YoY earnings growth (18.8%) and a consistent track record of earnings beats provide a bullish fundamental backdrop, but these are offset by bearish insider sentiment and a complete lack of technical momentum. The overall outlook is neutral as the value proposition is currently fighting against poor operational health signals.

Key Strengths

Deep value pricing with P/B ratio of 0.92
Strong earnings growth (YoY +18.8%) and revenue growth (YoY +9.6%)
Consistent history of beating earnings estimates over 25 quarters
Low P/E (10.81) and Forward P/E (8.96) relative to sector averages
Sustainable dividend payout ratio of 29.63%

Key Risks

Very weak Piotroski F-Score (2/9) indicating poor financial health trends
Bearish insider activity with recent officer sales
Zero technical momentum (Technical Trend: 0/100)
Recent Q/Q EPS growth decline of -24.0%
Regional banking sector sensitivity to interest rate volatility
AI Fair Value Estimate
Based on comprehensive analysis
$26.4
+50.7% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
66
Strong
Value
95
Future
70
Past
85
Health
20
Dividend
60
AI Verdict
Value Trap Risk
Key drivers: Extreme valuation discount, Critical health score failure, Strong historical earnings performance
Confidence
90%
Value
95/100

Ref P/E 10.81, PEG 1.05, Graham Number $26.4

Positives
  • Price is well below Graham Number
  • P/B < 1.0
  • Low PEG ratio of 1.05
Watchpoints
No urgent risks highlighted.
Future
70/100

Ref Growth rates

Positives
  • Strong YoY earnings growth
  • Positive Q/Q revenue growth
Watchpoints
  • Recent Q/Q EPS contraction
Past
85/100

Ref Historical trends

Positives
  • Long-term earnings beat consistency
  • Positive 5Y price change (+62.1%)
Watchpoints
No urgent risks highlighted.
Health
20/100

Ref Piotroski F-Score

Positives
No standout positives identified.
Watchpoints
  • Piotroski F-Score of 2/9 is in the 'Weak' category
Dividend
60/100

Ref Yield 2.97%, Payout 29.63%

Positives
  • Low payout ratio ensures safety
Watchpoints
  • Low overall dividend strength score (35/100)

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$17.52
Analyst Target
$20.38
Upside/Downside
+16.3%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for FNB and closest competitors.

Updated 2026-04-24
FNB
F.N.B. Corporation
Primary
5Y
+62.1%
3Y
+73.8%
1Y
+34.7%
6M
+14.1%
1M
+6.2%
1W
-2.3%
GBC
Glacier Bancorp, Inc.
Peer
5Y
-7.2%
3Y
+64.2%
1Y
+17.7%
6M
+12.8%
1M
+9.9%
1W
-0.5%
UBS
United Bankshares, Inc.
Peer
5Y
+36.3%
3Y
+50.8%
1Y
+31.3%
6M
+21.7%
1M
+6.5%
1W
-1.8%
ESN
Essent Group Ltd.
Peer
5Y
+33.3%
3Y
+63.0%
1Y
+14.7%
6M
+4.3%
1M
+9.8%
1W
+2.5%
MKT
MarketAxess Holdings Inc.
Peer
5Y
-65.4%
3Y
-45.9%
1Y
-20.2%
6M
+1.9%
1M
-3.1%
1W
-0.3%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
10.81
Forward P/E
8.96
PEG Ratio
1.05
P/B Ratio
0.92
P/S Ratio
3.63
EV/Revenue
4.5
EV/EBITDA
N/A
Market Cap
$6.23B

Profitability

Profit margins and return metrics

Profit Margin 34.11%
Operating Margin 42.01%
Gross Margin N/A
ROE 8.86%
ROA 1.18%

Growth

Revenue and earnings growth rates

Revenue Growth +9.6%
Earnings Growth +18.8%
Q/Q Revenue Growth +22.79%
Q/Q Earnings Growth +17.1%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$7.48

Quarterly Earnings History

EPS performance vs analyst estimates

2026-07-16
$N/A
2026-04-16
$0.38
-1.0% surprise
2026-01-20
$0.5
+22.7% surprise
2025-10-16
$0.41
+10.4% surprise

Financial Services Sector Comparison

Comparing FNB against 763 companies in the Financial Services sector (133 bullish, 317 neutral, 313 bearish)
P/E Ratio
10.81
This Stock
vs
38.21
Sector Avg
-71.7% (Discount)
Return on Equity (ROE)
8.86%
This Stock
vs
-1.82%
Sector Avg
-586.6% (Below Avg)
Profit Margin
34.11%
This Stock
vs
75.74%
Sector Avg
-55.0% (Weaker)
Revenue Growth
9.6%
This Stock
vs
37.18%
Sector Avg
-74.2% (Slower)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

DELIE VINCENT J JR
Chief Executive Officer
Stock Award
2026-03-18
227,919 shares · $3,671,775
CALABRESE VINCENT J. JR
Chief Financial Officer
Stock Award
2026-03-18
63,833 shares · $1,028,350
ORIE JAMES G
Officer
Stock Award
2026-03-18
23,615 shares · $380,438
GUERRIERI GARY LEE
Officer
Stock Award
2026-03-18
39,093 shares · $629,788
DUTEY JAMES L
Officer
Stock Award
2026-03-18
11,716 shares · $188,745
DAVID BRYANT MITCHELL
Officer
Stock Award
2026-03-18
30,280 shares · $487,811
DELIE VINCENT J JR
Chief Executive Officer
Stock Award
2026-02-18
83,499 shares · $1,518,012
CALABRESE VINCENT J. JR
Chief Financial Officer
Stock Award
2026-02-18
20,628 shares · $375,017
ORIE JAMES G
Officer
Stock Award
2026-02-18
8,911 shares · $162,002
GUERRIERI GARY LEE
Officer
Stock Award
2026-02-18
11,860 shares · $215,615
DUTEY JAMES L
Officer
Stock Award
2026-02-18
3,587 shares · $65,212
DAVID BRYANT MITCHELL
Officer
Stock Award
2026-02-18
9,030 shares · $164,165
CHO ALFRED D.
Officer
Stock Award
2026-02-18
8,911 shares · $162,002
GUERRIERI GARY LEE
Officer
Sell
2025-12-10
15,000 shares · $265,050
DUTEY JAMES L
Officer
Sell
2025-12-02
40,000 shares · $670,080
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

8-K
8-K
2026-04-17

FNB Corporation likely filed this 8-K to announce its first-quarter financial results for 2026.

8-K
8-K
2026-04-14

F.N.B. Corporation reported its first-quarter financial results for 2026.

DEF 14A
DEF 14A
2026-03-25

FNB filed a definitive proxy statement (DEF 14A) on March 25, 2026, providing shareholders with necessary information and voting materials for the upcoming annual meeting.

10-K
10-K
2026-02-24

FNB filed its 10-K on February 24, 2026, providing a comprehensive overview of its business operations and financial condition. The filing includes detailed sections on risk factors and management's discussion and analysis of the company's results of operations.

8-K
8-K
2026-01-21

FNB Corporation filed an 8-K to report its fourth quarter and full-year 2025 financial results.

8-K
8-K
2025-11-05

FNB Corporation filed an 8-K on November 5, 2025, likely to announce its third-quarter financial results.

10-Q
10-Q
2025-11-05

FNB filed its quarterly 10-Q report on November 5, 2025. While the filing includes a section for risk factors under Item 1A, no specific financial highlights or detailed risk descriptions were provided in the available excerpt.

8-K
8-K
2025-10-17

FNB Corporation filed an 8-K on October 17, 2025, likely to announce its third-quarter financial results.

8-K
8-K
2025-08-26

FNB Corporation filed an 8-K on August 26, 2025, likely to report its quarterly financial results.

10-Q
10-Q
2025-08-06

FNB filed its quarterly 10-Q report on August 6, 2025. The filing includes a section on risk factors under Item 1A, although specific financial highlights and risk details were not provided in the available excerpt.

8-K
8-K
2025-07-18
8-K
8-K
2025-05-12
10-Q
10-Q
2025-05-07
8-K
8-K
2025-04-17
DEF 14A
DEF 14A
2025-03-27
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
STRONG_BUY
8 analysts
Keefe, Bruyette & Woods
2026-04-20
Maintains
Outperform Outperform
Truist Securities
2026-04-20
Maintains
Buy Buy
Truist Securities
2026-01-22
Maintains
Buy Buy
Piper Sandler
2026-01-22
reit
Overweight Overweight

Past News Coverage

Recent headlines mentioning FNB from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile